AJP - Regu Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 285: R1430-R1438, 2003. First published August 7, 2003; doi:10.1152/ajpregu.00331.2003
0363-6119/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/6/R1430    most recent
00331.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pelis, R. M.
Right arrow Articles by Renfro, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pelis, R. M.
Right arrow Articles by Renfro, J. L.

THIRST AND VOLUME, ELECTROLYTE HOMEOSTASIS

Cortisol alters carbonic anhydrase-mediated renal sulfate secretion

Ryan M. Pelis,1,2 James E. Goldmeyer,1 Joseph Crivello,1 and J. Larry Renfro1,2

1Department of Physiology and Neurobiology, University of Connecticut, Storrs, Connecticut 06269; and 2Mount Desert Island Biological Laboratory, Salisbury Cove, Maine 04672

Submitted 17 June 2003 ; accepted in final form 5 August 2003


   ABSTRACT
TOP
 ABSTRACT
METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
Active transepithelial sulfate secretion rate by winter flounder renal proximal tubule epithelium in primary culture (fPTC) is dependent on intracellular carbonic anhydrase (CA) and enhanced by cortisol. To further evaluate this relationship, a partial cDNA clone (327 bp) of carbonic anhydrase II (CAII) with high sequence similarity to CAII from numerous species including fish, chicken, and human was obtained from fPTCs. The majority of CA activity and CAII protein was present in the cytosol of fPTCs; however, significant amounts of both (in addition to SDS-resistant CA activity, i.e., CAIV-like isoform) were present in concentrated plasma membranes. CAII from concentrated membranes migrated differently than purified CAII on nondenaturing PAGE gels, suggesting that CAII associates with another membrane component. Treatment of fPTCs with the cell-soluble CA inhibitor methazolamide (100 µM) caused a 58% reduction in active transepithelial SO42- secretion. fPTCs that were previously cultured under high-cortisol concentrations, when subjected to 5 days of low physiological levels of cortisol, had decreased CA activity (28%), CAII protein abundance (65%), and net active SO42- secretion (28%), with no effect on epithelial differentiation. Methazolamide and low-cortisol treatment in combination inhibited net active SO42- secretion 56%, which was not different than the effect of methazolamide treatment alone. These data indicate that cortisol directly increases renal CA activity, CAII protein abundance, and CA-dependent SO42- secretion in the marine teleost renal proximal tubule.

renal proximal tubule; marine teleost; carbonic anhydrate II; primary culture

THE INGESTION OF seawater (25 mM SO42-) by marine teleosts leads to absorption of excess SO42-, and a powerful active renal secretory process transfers SO42- into the urine, maintaining a plasma level of 0.5-0.6 mM (21, 37). Renal tubular SO42- secretion in these animals involves unique electroneutral SO42-/anion exchange mechanisms on basolateral and apical membranes of the proximal tubule cells (37, 38). Movement of SO42- across the basolateral membrane (interstitium-to-cell) is facilitated by exchange for intracellular OH-. The latter has no effect on the apical SO42- exchanger where luminal HCO3- is the most effective counteranion for SO42- exit, cell-to-lumen. Inhibitors of intracellular carbonic anhydrase (CA) significantly reduce SO42- secretion both in vitro and in vivo (36). Presumably, CA inhibition decreases counteranion availability, thereby decreasing the driving force for basolateral and (or) apical SO42-/anion exchange.

Renal proximal tubule CA has also been linked to transepithelial SO42- reabsorption in chickens (12), and while not directly linked to SO42- transport, CA activity in the mammalian renal proximal tubule facilitates HCO3- reabsorption and H+ secretion thereby promoting urinary acidification (42). More than 95% of renal CA activity in mammals is attributed to cytosolic CA, with the remaining ~5% membrane bound (32, 59). Four CA isoforms (CAII, CAIV, CAXII, and CAXIV) have been identified in the mammalian renal proximal tubule. CAII is cytosolic (4, 42), whereas CAIV (8), CAXII (33), and CAXIV (24) are localized to the basolateral membrane (CAXII) or both basolateral and apical membranes (CAIV and CAXIV). Whereas CAII has been demonstrated in chicken proximal tubule (12), its presence in marine flounder proximal tubule is yet to be determined.

Several studies suggest that CA expression may be regulated; for example, the avian CAII gene contains a vitamin D3 response element in the promoter regions (34). Metabolic acidosis in rabbits increases CAII and CAIV activity (6, 7, 58) and mRNA expression (43, 53, 58) in the kidney, changes that function to enhance acid excretion. Similarly, renal CAII mRNA levels increase following acidosis in a cyprinid teleost (Tribolodon hakonensis) (22). Glucocorticoid levels increase during metabolic acidosis (31, 57), which may implicate cortisol in the control of renal CA expression during acidosis. Sexual maturation induces an increase in CA activity in red blood cells and kidneys of rabbits (6), and dexamethasone (a cortisol agonist) treatment (in vivo) of rats accelerates the maturation-induced increase in CA activity in the brain (13). CA activity in red blood cells is increased by in vitro and in vivo cortisol treatment (39).

SO42- secretion, reabsorption, and urinary acidification are all affected, directly or indirectly, by glucocorticoids (3, 12, 36), respectively. Teleosts that tolerate varying salinities obviously must regulate renal excretion. Bern (2) implicated cortisol in the adaptation of teleosts to seawater; indeed, it was termed the "seawater-adapting" hormone. Renfro (35) showed that acclimation of seawater winter flounder to 10% seawater (SO42- free) reduced SO42- clearance ratios from 12 to less than 1 and concurrently decreased renal epithelial cell apical SO42-/HCO3- exchange. Clearance ratios greater than one and enhanced apical SO42-/HCO3- exchange were restored by daily injections of dexamethasone (60 µg/100 g body wt) for 5 days. Glucocorticoids also increase SO42- excretion in birds and mammals through effectively decreasing apical Na-dependent SO42- reabsorption (12, 40). The observations that renal tubular SO42- transport is cortisol dependent, metabolic acidosis stimulates renal CA expression, and CA activity is required for full proximal tubular SO42- secretion prompted the present investigation. The results suggest that cortisol stimulates renal proximal tubule CA activity, CAII protein abundance, and CA-dependent SO42- secretion.


   METHODS
TOP
 ABSTRACT
 METHODS
RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
Animals. Winter flounder, Pleuronectes americanus, were obtained by otter trawl in Frenchman's Bay, Maine, or in Long Island Sound, Connecticut. Animals (250-400 g) were held in flowing seawater (17-19°C) or in Living Stream Units (Toledo) filled with artificial seawater (Utikem) at 12°C. Animal use followed the newest guiding principles for research (1).

Solutions and chemicals. Modified medium 199 with Earle's salts (M199, Sigma Chemical, St. Louis, MO) was supplemented with (in mM) 30.0 NaCl, 4.2 NaHCO3, 1.0 L-glutamine, 25.0 HEPES, 14.75 NaOH (pH 7.5, 347 mosmol/kgH2O), and 20 mg/l tetracycline. Modified M199 was supplemented with 10 µg/ml insulin, 5 µg/ml hydrocortisone, and 10% flounder serum to form the final plating medium. Ca- and Mg-free solutions (CMF) used for removing extrarenal tissues contained the following (in mM): 150.0 NaCl, 4.0 KCl, 0.5 NaH2PO4, 4.2 NaHCO3, 25.0 HEPES, 5.5 glucose, 0.3 ethylenediaminetetraacetic acid, 14.75 NaOH (pH 7.5), and 20 mg/l tetracycline. Flounder saline (FS) contained (in mM) 150.0 NaCl, 4.0 KCl, 2.0 CaCl2, 1.0 MgSO4, 0.4 NaH2PO4, 4.2 NaHCO3, 25.0 HEPES, 5.5 glucose, 1.0 L-glutamine, and 14.75 NaOH (pH 7.5).

Preparation and primary culture of flounder renal proximal tubule epithelium. The method shown here was first described by Dickman and Renfro (11) and then modified by Gupta and Renfro (19). Briefly, kidneys were perfused with modified M199, removed, and tubules were teased apart. Hematopoietic and lymphoid tissues were removed by brief incubation of tubules in CMF containing 0.2% trypsin at 22°C. Epithelial cells were released from tubule fragments by 3 days of trypsinization (5°C) in M199 supplemented with 0.05% trypsin. Dissociated cells were washed, suspended in culture medium, and plated on native rat-tail collagen. Collagen gels were released after 4 days, and after 12 days, the epithelial monolayers had contracted from the initial 35-mm diameter to 17 mm and had assumed fully differentiated transepithelial transport capabilities.

Cortisol levels in plasma and culture medium were measured by radioimmunoassay (Diagnostic Products). Plasma cortisol levels from winter flounder sampled in October and February were highly variable (8.4 x 10-9 - 3.5 x 10-7 M, n = 15). Primary cultures of flounder renal proximal tubule epithelium (fPTCs) were supplemented with cortisol (7.3 x 10-6 M) and removal of added cortisol from culture medium 5 days before experimental analysis resulted in levels that were at the lower end of the physiological range (6.3 x 10-9 M, n = 7).

Preparation of total mRNA from fPTCs. A single fPTC containing ~107 cells was homogenized to a fine powder under liquid nitrogen using mortar and pestle. Total RNA was isolated with a Qiagen RNeasy mini kit. Purified RNA was stored in 200 µl of RNase-free water. Total RNA was quantified with Ribogreen (Molecular Probes) and by comparison to RNA standard curve. The final concentration of RNA was adjusted to 100 ng/µl.

Isolation of mRNA from 1.0 mg of total RNA obtained was carried out as described by the Qiagen Oligotex mRNA kit. mRNA was eluted into 40 µl of elution buffer yielding a final mRNA concentration of 1 ng/µl.

RT-PCR method for detecting CAII in fPTCs. The isolated mRNA was used for RT-PCR as described in the Qiagen one-step RT-PCR kit. Both the initial reverse transcription of mRNA and the subsequent PCR of CAII sequences were carried out in a single step with degenerate primers provided by Dr. Steven Gehnrich, Salisbury State, Maryland. The forward and reverse primer sequences were 5'CAGTTBCAYYTKCACTGG and 5'GGNGGNGTNGTNAGNGANCC, respectively. The primers (2 µM) and 2 ng of template mRNA were used in the RT-PCR reaction. The reverse transcription reaction was carried out at 50°C for 30 min followed by a 15-min incubation at 95°C to denature the reverse transcriptase activity. The PCR reaction was run for 37 cycles with a denaturing temperature of 94°C, an annealing temperature of 55°C, and an elongating temperature of 72°C. PCR products were separated on a 2% agarose gel and stained with Gel-Star (Fisher). A single band was predominant at 329 bp.

Cloning and sequencing of RT-PCR product from fPTC total mRNA. Cloning of PCR products was carried out according to the protocol of Hamilton et al. (20) with a few minor modifications. The RT-PCR product was cleaned with Qia-quick spin tubes and ligated to SNX linker fragments, after digestion with Mung bean exonuclease to create blunt ends and dephosphorylation with calf intestinal phosphate. Ligation to the SNX linker occurred in the presence of XMN I. NHE I was used to cut the SNX linker for insertion into p-Bluescript. The 329-bp product was chosen for sequencing. Positive colonies from white/blue X-gal/IPTG-based selection on ampicillin-positive plates were selected at random and sequenced by the Yale University HHMI/KECK Biotechnology Resource Laboratory, New Haven, CT. Blast searches were used to compare the cloned CAII DNA fragment to published DNA and peptide sequences. The partial P. americanus CAII cDNA was deposited in GenBank with accession no. AY321311 [GenBank] .

Measurement of CA biochemical activity. Culture medium from individual fPTCs was aspirated and fPTCs were rinsed in 1 ml of 150 mM NaCl. Individual fPTCs were transferred to 200 ml of ice-cold 150 mM NaCl and rinsed for 30 min. This step was repeated once. Epithelial cells were scraped from the collagen substratum using a glass microscope slide, aspirated, and placed in a microcentrifuge tube. Cells were pelleted by centrifugation (11,000 g, 90 s) and resuspended in 100 µl of H2O. The method for determining CA biochemical activity is a colorimetric assay that monitors change in pH (5). The assay was conducted at 0.5°C. The sample mixture was prepared by adding 10 µl of cell suspension to 185 µl H2O containing 5 µl of 1-octanol. CAIV is a membrane-bound CA, which unlike other CA isozymes is resistant to SDS (0.2-10%; 7). SDS (1%) and 15 µl 1-octanol (to prevent foaming) were included in the sample mixture when examining CAIV activity only. CO2 was bubbled into the sample mixture and 200 µl of buffer/indicator mix (5.0 mM Tris·HCl, 20 mM imidazole, and 0.4 mM para-nitrophenol) were added to the sample mixture. A yellow-to-clear color change indicated the reaction endpoint, and a stopwatch was used to monitor the time for this to occur. The uncatalyzed reaction was monitored in the absence of sample. Samples were run with and without 100 µM methazolamide (CA inhibitor) to determine total CA activity in the sample. Protein concentration among samples was determined by a protein assay (Bio-Rad). Total CA activity is expressed in enzyme units per milligram of protein, and 1 enzyme unit (EU) equals one-half the time for the uncatalyzed reaction endpoint.

Isolation of fPTC cell lysates, plasma membranes, and cytosolic fractions for determination of CA activity and CAII protein expression. Culture medium from individual fPTCs was aspirated, and fPTCs were rinsed in 1 ml of 150 mM NaCl followed by two additional washes (30 min each) in 200 ml of ice-cold 150 mM NaCl. Cells were removed from the collagen substratum by scraping with a glass microscope slide and placed in 50 ml of ice-cold 150 mM NaCl, pelleted at 5,000 g for 10 min, lysed in 300 µl of water, and a sample (cell lysate) was saved. The cell lysate was centrifuged at 30,000 g for 30 min at 4°C. The supernatant (cytosolic fraction) was removed and the pellet (membrane fraction) was resuspended in 100 µl of water. CA activities of cell lysate, plasma membranes, and cytosolic fraction were assayed. The cell lysate, plasma membranes, and cytosolic fraction were also diluted in Kaman buffer for SDS-PAGE.

Preparation of plasma membranes from fPTCs. fPTCs were rinsed in FS and the epithelium was scraped from the collagen substratum with a glass microscope slide. Cells were suspended and pelleted in FS by centrifugation at 5,000 g for 10 min at 4°C. Cells were lysed in a 1,000-fold dilution of lysis buffer (5 mM NaH2PO4, pH 7.0) by syringing with a 23-gauge needle. Lysed cells were further diluted 1:40 before centrifugation at 49,000 g for 45 min at 4°C. Pelleted membranes were diluted 1:1,000 with lysis buffer, syringed, and further diluted 1:40. Cell membranes were centrifuged at 49,000 g and resuspended in H2O (±1% SDS) for measurement of CA biochemical activity, Kaman buffer (2.3% SDS, 5% {beta}-mercaptoethanol, 10% glycerol, 0.5% saturated bromophenol blue, 62.5 mM trizma base, pH 6.8) for SDS-PAGE, or solubulized with 0.5% t-octylphenoxypolyethoxyethanol (Triton X-100) and placed in Kaman buffer without SDS or {beta}-mercaptoethanol for nondenaturing PAGE. All solutions were ice-cold and contained the following protease inhibitors (in µM) 100 4-(2-aminoethyl) benzenesulfonylfluoride HCl, 0.08 aprotinin, 5.0 bestatin, 1.5 E-64, 2.0 leupeptin, and 1.0 pepstatin A.

Preparation of rat red blood cell membranes. Packed red cells (500 µl) were diluted in 5 ml of ice-cold lysis buffer (5 mM sodium phosphate, pH 8.0) containing the aforementioned protease inhibitors and centrifuged at 5,000 g for 5 min. This step was repeated five times. Membranes were incubated in PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.3 with HCl) for 30 min on ice and solubulized by incubation in lysis buffer containing 0.5% Triton X-100. Solubulized membranes were centrifuged at 16,000 g for 5 min, and the resulting supernatant was placed in nondenaturing Kaman buffer for nondenaturing PAGE.

SDS-PAGE, nondenaturing PAGE, and immunoblotting. Individual fPTCs, cell lysates, plasma membranes, or cytosolic fractions were placed in Kaman buffer, vortexed, centrifuged at 11,000 g for 90 s, and the supernatant was boiled for 5 min. SDS-PAGE was conducted using 4-12% polyacrylamide gels. For nondenaturing PAGE, plasma membranes (fPTCs and rat red cell membranes) that were solubulized in 0.5% Triton X-100 were placed in Kaman buffer without SDS or {beta}-mercaptoethanol. Samples for nondenaturing PAGE were not boiled and were run on 5% polyacrylamide gels. After SDS-PAGE and nondenaturing PAGE, proteins were transferred to polyvinylidene fluoride membranes (Milipore, Bedford, MA) that were then incubated in blocking buffer [PBS containing 0.05% polyoxyethylene-sorbitan monolaurate (Tween 20), 0.01% antifoam A, 0.02% NaN3, and 10% nonfat dry milk] overnight at 4°C followed by 1-h incubation at room temperature with primary antibodies diluted 1:500 in blocking buffer. Primary antibodies included sheep anti-human CAII IgG (Accurate, Westbury, NY) and a monoclonal directed against human actin (Sigma). Membranes were washed three times with PBS (10 min each) and once in phosphate-free buffer (150 mM NaCl, 10 mM Tris-base, 40 mM Tris·HCl, pH 7.5). Membranes were incubated for 1 h at room temperature with secondary antibodies diluted 1:1,000 in phosphate-free buffer containing 10% nonfat dry milk. Secondary antibodies included alkaline phosphatase-conjugated donkey anti-sheep IgG (Sigma) and alkaline phosphatase-conjugated goat anti-mouse IgG (StressGen, Victoria BC, Canada). Membranes were washed four times in phosphate-free buffer and signals were detected by 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (Sigma) according to the manufacturer's protocol. CAII protein expression among treatment groups was determined using densitometric analysis (National Institutes of Health image 1.60) and actin expression was used to control for differences in protein loading among samples.

Ussing chamber studies and determination of transepithelial SO42- fluxes. fPTCs were mounted in Ussing chambers with an aperture size of 0.332 cm2. Fluid volume was 1.2 ml/hemichamber, and temperature was maintained at a constant 20°C with water circulated on the outside surface of the chambers by a Lauda RM6 Electronic water bath. Fluid inside the chambers was constantly and vigorously stirred with small magnetic stir bars turned by external stir-plates. Chambers were insufflated with humidified 99% O2-1% CO2. Transepithelial potential difference (TPD) was determined with Ag/AgCl electrodes connected to the luminal and peritubular compartments with 3 M KCl-2% agar bridges. Electrical properties were determined with a pair of computer-controlled, high-impedence automatic dual-voltage clamps (DVC 1,000; World Precision Instruments, Sarasota, FL). Electrode asymmetry was corrected at the beginning and end of each experiment and fluid resistance was compensated. Short-circuiting electrodes were connected to the luminal and peritubular solutions with 3 M KCl-2% agar bridges. Transepithelial resistance (TER) was determined from the change in TPD produced by a brief 10-µA pulse controlled by the voltage clamps.

Tissues were continuously short-circuited during flux determinations. Unidirectional tracer fluxes were initiated by the addition of 1.0-2.0 µCi 35S to the appropriate hemichamber. Duplicate 50-µl samples were taken from the unlabeled side at 30-min intervals over a period of 1.5 h and replaced with equal volumes of unlabeled solution. The specific activity of the labeled solution was determined at the beginning and end of each experiment. Net flux was calculated as the difference between unidirectional secretory and reabsorptive fluxes. Tissues used in a given experiment were prepared from the same culture batch. Proximal tubule-like function and integrity were assessed by measurement of TPD, TER, and phlorizin-sensitive glucose current (Iglu).

Statistics. Experimental results are expressed as means ± SE, except flux data, which are presented as means + SE. For examining differences in CA biochemical activity and CAII protein abundance, paired comparisons of sample means were done using Student's t-test. One-way ANOVA was used to test the effects of methazolamide, low cortisol, and methazolamide and low cortisol in combination. Tukey's HSD test was used for pairwise comparison of individual treatments. All statistical analyses were done using Statistica (StatSoft, Tulsa, OK) and deemed significant if P < 0.05.


   RESULTS
TOP
 ABSTRACT
 METHODS
 RESULTS
DISCUSSION
 DISCLOSURES
 REFERENCES
 
Reverse transcription of fPTC mRNA with CAII-specific primers produced a single PCR product of 329 bp (Fig. 1A). The 329-bp fragment was cloned (Fig. 1B) and exhibited high sequence (nucleotide) homology to CAII from the European flounder (Platichthys flesus, 93%), Atlantic salmon (Salmo salar, 72%), big-scaled redfin (T. hakonensis, 71.1%), longnose gar (Lepisosteus osseus, 68.1%), chicken (Gallus gallus, 64.2%), and human (64%). The cloned fragment encodes 109 amino acids (aa), which represents 42% of the peptide (260 aa).



View larger version (44K):
[in this window]
[in a new window]
  		Fig. 1. A: RT-PCR for flounder renal carbonic anhydrase II (CAII). mRNA isolated from flounder renal proximal tubule epithelium in primary cultures (fPTCs) was reverse transcribed and amplified using degenerate primers to CAII. The RT-PCR product was run on a 2% agarose gel and stained with Gel-Star. A single product of 329 bp was obtained (CAII). No product was obtained when cDNA template was omitted (control). Molecular weight markers (MW) are labeled in bp. B: partial cDNA clone of winter flounder CAII and its deduced amino acid sequence. Amino acids are identified by standard 1-letter code. Amino acid numbers begin at 92 with glutamine and end with proline at position 200.

 

When probed with an anti-human CAII antibody, both rat red blood cells and winter flounder red blood cells exhibited intense immunoreactive signals corresponding to 29 kDa on immunoblots (Fig. 2A). Although less intensely stained than in red blood cells, CAII was present in fPTC cell lysates and in the cytosolic fraction. CAII appeared to be almost entirely absent from the plasma membrane (Fig. 2A). CA enzymatic activity measurements showed that ~85% of total CA activity (fPTC lysate, 2.638 EU) was in the cytosolic fraction (2.24 EU). When plasma membranes were concentrated, an intense signal corresponding to CAII was present (Fig. 2B). Compared with the cell lysate, enzymatic activity in the concentrated plasma membranes was enriched 1.65-fold (4.86 vs. 8.05 EU/mg protein). Of the CA biochemical activity in the concentrated plasma membranes, 56% was inhibited by 1% SDS (data not shown). Under nondenaturing conditions (nondenaturing PAGE), both fPTC plasma membranes and rat red blood cell membranes were immunoreactive for CAII (Fig. 2C). Unlike SDS-PAGE, CAII from rat red blood cells and fPTC plasma membranes migrated differently (the 5% gel alone does not allow molecular weight determination) than purified CAII, which migrates as three charge isomers on nondenaturing PAGE gels (Sigma Technical Bulletin No. MKR-137).



View larger version (74K):
[in this window]
[in a new window]
  		Fig. 2. A: immunoblot showing CAII protein expression from rat (rRBC) and flounder (fRBC) red blood cell lysates and the lysate, plasma membrane (mem.), and cytosolic fractions from fPTCs (6 fPTCs). The cell lysate, plasma membrane, and cytosolic fractions were prepared from the same fPTCs. All tissues were run on 4-12% SDS-PAGE gels. A band corresponding to 29 kDa (CAII) was present in all tissues examined. Differences in protein loading are reflected in the staining intensity of actin (45 kDa). B: immunoblot showing purified bovine CAII and CAII from concentrated fPTC plasma membranes. The plasma membranes were concentrated by using more fPTCs (10 fPTCs) and by suspending the membranes in a smaller volume of Kaman buffer. Tissues were run on 4-12% SDS-PAGE gels. C: immunoblot showing CAII protein expression from purified bovine CAII, rat red blood cell plasma membranes, and fPTC plasma membranes. Purified CAII, rat red blood cell plasma membranes, and fPTC plasma membranes were solubulized with 0.5% Triton X-100 before run out on 5% nondenaturing polyacrylamide gels.

 

Analysis of immunoblots indicated that CAII protein abundance in fPTC cell lysates was 65% lower in fPTCs exposed to low cortisol for 5 days (Fig. 3). In addition, exposure to low cortisol caused a 28% reduction in CA enzymatic activity in fPTC cell lysates (Fig. 3).



View larger version (57K):
[in this window]
[in a new window]
  		Fig. 3. Differences in CAII protein expression and CA biochemical activity in fPTCs either exposed to normal levels (control) or low physiological levels of hydrocortisone for 5 days (low cortisol). Values are means ± SE of n = 3 (CA activity) and n = 4 (CAII protein expression) fPTC cell lysate preparations. CAII protein levels are expressed as the ratio of CAII/actin. Whereas this ratio could be affected by changes in actin levels, no functional dedifferentiation of the epithelium was detected in this time frame (see Table 1). The 5-day period with low cortisol resulted in very faint CAII staining, and more tissue (total protein) was loaded to compensate resulting in a greater actin signal in the low-cortisol group. Cell lysates were run on 4-12% SDS-PAGE gels. CA biochemical activity is expressed as enzyme units (EU)/mg protein. *Significantly different from control (P < 0.05, paired t-test).

 


View this table:
[in this window]
[in a new window]
  		Table 1. Effects of various treatments on transepithelial electrical properties generated by fPTCs

 
Control fPTCs actively secreted SO42- at a net rate of 114.4 ± 5.81 nmol·cm-2·h-1 (Fig. 4). Treatment of fPTCs with the cell-soluble CA inhibitor methazolamide significantly reduced net active SO42- secretion to 47.9 ± 3.44 nmol·cm-2·h-1. The 58% inhibition in net active SO42- secretion following methazolamide treatment was due to a decrease in the unidirectional secretory flux (118.4 ± 6.43 to 52.6 ± 3.47 nmol·cm-2·h-1). Exposure to low cortisol reduced the unidirectional secretory flux to 92.9 ± 9.07 nmol·cm-2·h-1, which inhibited net active SO42- secretion 28%. Low cortisol and methazolamide treatment in combination reduced net active SO42- secretion to 43.8 ± 5.06 nmol·cm-2·h-1. The 61% inhibition in net active SO42- secretion following exposure to low cortisol and methazolamide together was not significantly different from methazolamide treatment alone. The unidirectional reabsorptive flux was not altered by methazolamide treatment, low cortisol, or methazolamide treatment and low cortisol in combination. None of the treatments had an effect on TER, TPD, or Iglu (Table 1). In the case of low-cortisol treatment, this is especially noteworthy because this steroid is a known differentiating factor (15), and after 12 days in low cortisol considerable dedifferentiation occurs in fPTCs (19).



View larger version (19K):
[in this window]
[in a new window]
  		Fig. 4. Effects of methazolamide (Mthz; 100 µM), supplementing with low physiological levels of hydrocortisone for 5 days (low cortisol), and methazolamide and low hydrocortisone in combination (Mthz + low cortisol) on the unidirectional secretory [peritubular-tolumen (P-L)], unidirectional reabsorptive [lumen-to-peritubular (L-P)], and net SO42- fluxes across fPTCs. Control and methazolamide-treated fPTCs were supplemented with normal levels of culture medium hydrocortisone throughout. Fluxes shown were obtained at steady state following tracer additon (t = 1.5 h) and are means + SE (vertical line) of 10 preparations. Different letters indicate significant differences among treatment groups (P < 0.05, Tukey's HSD).

 


   DISCUSSION
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
DISCLOSURES
 REFERENCES
 
Previous work (36) demonstrated CA enzymatic activity in fPTCs, and unlike other studies that had used whole kidney tissue to establish whether marine teleost renal tubule contained CA activity (16, 17, 30, 51, 52), the finding was not confounded by the presence of hematopoietic tissue. Furthermore, it was shown that the rate of renal tubular SO42- secretion is dependent on intracellular CA activity. With the use of the same culture system, the present study revealed 1) that proximal tubular CA activity includes at least CAII and, probably, CAIV, 2) that CA activity and CAII protein are both cytosolic and membrane associated and increased by cortisol, and 3) that increased CAII protein and CA activity in this tissue are correlated with an increase in a component of SO42- transport that is sensitive to cortisol.

In the present study, RT-PCR and degenerate primers to CAII were used to clone a 329-bp fragment from fPTCs that exhibited high sequence (nucleotide) similarity to CAII from numerous species including human (64%). This unequivically demonstrates that CAII is specifically expressed in proximal tubule epithelium of winter flounder. Several key amino acid residues that are essential for the catalytic activity of CAII were present in the cloned fragment (Fig. 1B). H94, H96, and H119 reside in the active site pocket and are essential for binding Zn2+, which when complexed with OH- (Zn-OH) forms the nucleophile required for enzymatic catalysis (25). Q92, E117, and T199 are considered second-shell residues that accept hydrogen bonds from H94, H119, and the Zn-OH, respectively, thereby functioning to fine-tune protein-zinc affinity (9, 26).

Measurements of CA activity in fPTCs indicated that 85% of enzymatic activity was in the cytosol with the remaining 15% membrane associated. More than 95% of CA activity in the rat and human kidney is contained within the cytosol (32, 59). In contrast, only 86% of CA activity in the dog kidney is attributable to cytosolic CA (41). In the mammalian kidney, CAII is cytosolic, whereas CAIV, CAXII, and CAXIV are tethered to the plasma membrane (42). When immunoblots were probed with a polyclonal antibody against human CAII, a single band of 29 kDa was apparent from winter flounder red blood cells and fPTC cell lysates and was identical in size to CAII from rat red blood cells. When cytosolic and membrane fractions were isolated, there was strong immunoreactivity for CAII in the cytosolic fraction, whereas the membrane fraction displayed weak immunoreactivity. Taken together, these data indicate that the total amounts of CA activity and CAII protein expression in renal proximal tubule epithelial cells of marine teleosts are highest in the cytosol.

When plasma membranes from fPTCs were concentrated, CA activity was enriched 1.65-fold. The enrichment of CA activity in plasma membrane preparations from dog renal tissue has been previously demonstrated (41). CA activity in fPTC plasma membranes (8.05 EU/mg protein) was similar to the enzymatic activity found in apical (12.2 EU/mg protein) and basolateral (13.0 EU/mg protein) membranes of rat renal tubular cells (59). Approximately 50% of the CA activity in the fPTC plasma membranes was inhibited by 1% SDS. CAIV is an extracellular glycosylphosphatidylinositol-anchored CA that contains two disulfide bridges allowing it to maintain its structure and catalytic activity in the presence of 0.2-10% SDS (7). The presence of SDS-resistant enzymatic activity in fPTC plasma membranes may suggest that ~50% of CA activity is due to a CAIV-like isoform. Membrane-associated CA (including CAIV) is essential for HCO3- reabsorption in the mammalian renal proximal tubule (28, 54). At this time, a function for CAIV in the marine teleost renal tubule is uncertain because CA inhibition (in vivo) has no effect on HCO3- excretion or urinary pH (23) and an extracellular CA inhibitor, F3500, has no effect on net SO42- secretion in fPTCs (36). CAII protein was shown to be present in concentrated fPTC plasma membranes and migrated identically to purified bovine CAII (29 kDa) on SDS-PAGE. Although CAII appears to be present at the plasma membrane, it remains to be determined if CAIV, CAXII, and/or CAXIV are present in renal proximal tubule epithelial cells of marine teleosts.

The question that remains, however, is why CAII occurs at the plasma membrane when it is supposedly a soluble isoform? One possible explanation for membrane-associated CAII is that, due to nonspecific binding, soluble CAII had contaminated the plasma membranes during their preparation. Wistrand and Kinne (59), however, showed that when exogenous CAII was added to renal homogenates, the additional enzyme was readily washed out, suggesting that CA activity in the plasma membranes was not due to contamination with soluble CAII. When rat red blood cell membranes and fPTC plasma membranes were run on nondenaturing PAGE gels, CAII migrated differently than purified CAII, raising the possibility that CAII is physically associated with an integral membrane protein. AE1 (band 3) has been shown to physically associate with CAII in the mammalian red blood cell (56) and is likely the reason why CAII from rat red blood cell membranes migrated differently than purified CAII on nondenaturing PAGE gels (see Fig. 2C). Both the Na+: HCO3- transporter (NBC1; 18) and the Na+/H+ exchanger (NHE1; 27) have also now been shown to reversibly associate with CAII.

The marine teleost renal proximal tubule is characterized by a pronounced SO42- secretory process that is partially inhibited (>50%) by concentrations of methazolamide and ethoxzolamide (10-100 µM) that inhibit 100% of CA enzymatic activity (36). Similarly, in the present study, methazolamide treatment (100 µM) of fPTCs resulted in a 58% reduction in SO42- secretion. Presumably, CA inhibition reduces the dehydoxylation rate of HCO3- (HCO3- -> CO2 + OH-) thereby reducing the driving force for apical SO42-/HCO3- and(or) basolateral SO42-/OH- exchange. An explanation for only partial inhibition of renal tubular SO42- secretion may include the fact that the slower, uncatalyzed reaction can contribute and, although luminal HCO3- serves as the most efficient substrate, luminal Cl- can also serve as a counteranion for the apical SO42-/HCO3- (Cl-) exchanger (38). In the latter event, Na+-K+-ATPase and Na+/H+ exchanger activity are a likely source of the OH- gradient necessary for basolateral SO42-/OH- exchange and the movement of SO42- into the cell across the basolateral membrane (36).

As noted above, cortisol has been shown to stimulate CA activity in the mammalian brain (13) and red blood cell (39). Reducing cortisol to low physiological levels reduced CA activity 28% and CAII protein abundance 65% in fPTC cell lysates. The difference in cortisol effect on CA activity and CAII protein levels (see Fig. 3) is likely explained by the fact that enzymatic activity is not a linear function of CAII abundance and total CA activity is due to a CAIV-like isoform and possibly other CA isoforms as well. There may also be a nonlinear relationship between cytosolic CA abundance and membrane-associated CA. The latter may have a higher molar activity. The DADD peptide sequence in AE1, for example, strongly activates human CAII (44). Thus a reduction in soluble CAII protein may have less effect on total CA activity than a reduction in membrane-associated CAII. Concurrent with the reductions in CA activity and CAII protein abundance was a 28% inhibition in SO42- secretion. Exposure to low cortisol had no effect on TPD, Iglu, or TER, indicating that fPTCs remained in a fully differentiated state. Treatment with both methazolamide alone and methazolamide and low cortisol in combination decreased SO42- secretion by similar magnitudes (~60%). Taken together, these data suggest that cortisol affects the CA-mediated fraction of renal proximal tubular SO42- secretion.

Although it is thought that mineralocorticoids are absent in fish, a mineralocorticoid-like receptor displaying high-sequence homology to the mammalian mineralocorticoid receptor has been recently cloned from rainbow trout (Onchorhynchus mykiss) (10). Furthermore, the mineralocorticoid receptor of rainbow trout was shown to exhibit high affinity for cortisol (Kd = 1.9 nM) (10), and blockade of the mineralocorticoid receptor with spironolactone prevented cortisol-induced proliferation of gill chloride cells in rainbow trout exposed to ion-poor water (45). Therefore, in tissues coexpressing the glucocorticoid and mineralocorticoid receptors, competition for cortisol may exist. In hypophysectomized rats, CA activity is stimulated by aldosterone in a dose-dependent manner (49, 50). Additional work will be required to determine if the mineralocorticoid receptor is expressed in renal proximal tubule cells of the marine teleost and whether cortisol acts through the mineralocorticoid receptor and (or) glucocorticoid receptor to regulate CA activity, CAII protein abundance, and CA-mediated SO42- secretion.

In summary, two important new aspects of SO42- transport were noted in the present study. First, CA activity and CAII protein abundance in the marine teleost proximal tubule are cortisol senstive and consist of both cytosolic and membrane-associated components. Second, the level of CA activity in the proximal tubule influenced a component of SO42- transport that is sensitive to cortisol.

Perspectives

In his classical review of the physiology of CA, Maren (29) explores the relationship between fractional inhibition of this enzyme and the physiological effect. He points out that, based on CA biochemical assays, inhibitor concentrations sufficient to produce fractional enzyme inhibition of 0.992 have no apparent physiological effect on several standard functional parameters of kidney, eye, pancreas, and stomach. However, at inhibitor concentrations sufficient to cause fractional inhibition of 0.9976, renal HCO3- excretion increases and intraocular pressure decreases. That is, there appears to be a 500-fold excess of the enzyme in vivo because less than 1% of the enzyme is enough to maintain normal function in the majority of tissues. If CA is in such excess, why should a 30-50% change in renal CA activity cause physiologically important changes in HCO3- and SO42- transport, as seems to occur at the tubule level, for example, during chronic metabolic acidosis in rabbit kidney (7, 53) and following exposure of renal proximal tubule epithelium to low cortisol (present study)?

In mammalian red blood cells, the NH2 terminus of CAII contains five histidine residues that form an electrostatic association with three aspartate residues (LDADD motif) in the intracellular COOH terminus of the Cl-/HCO3- exchanger AE1 forming a transport "metabolon" (55, 56). The function of a transport metabolon is likely one of proximity, where the production of substrate occurs near the substrate's transport site, or reciprocally, there is more rapid removal of substrate from the transport site, thereby preventing competitive substrate buildup in an unstirred layer. This may be particularly important for exchangers where there is little asymmetry in the intra- and extracellular binding sites. Furthermore, although the mechanism is not known, CAII enzymatic activity is enhanced by synthesized peptides mimicking the COOH terminus of AE1 (44). Formation of such metabolons allows maximal transport activity and may provide a regulatory site (18, 47). In addition to AE1, Sterling et al. (47) showed that many other HCO3- transporters, including those found in the kidney, contain potential CAII-binding sites at their COOH termini. In the present study, CAII from fPTC plasma membranes migrated differently than purified bovine CAII on nondenaturing PAGE gels, which suggests that CAII associates with an integral membrane protein in renal proximal tubule cells. Although we did not clone the NH2 terminus of winter flounder CAII, CAII from other fish species contains histidine residues that match the five histidine residue binding sites for HCO3- transporters.

Because the most likely model of SO42- secretion in the marine teleost involves two anion exchangers in series (brush-border membrane, SO42-/HCO3-; basolateral membrane, SO42-/OH-), one could reasonably posit roles for a CAII metabolon at both poles of the cells. It is unlikely that CAII at the apical membrane would enhance exchange through dissipation of HCO3- following exchange for intracellular SO42- because at physiological intracellular pH, the ratio of HCO3- to CO2 is ~20:1 (14). However, it is entirely possible that CO32-, rather than HCO3-, is being transported on the apical SO42-/anion exchanger (SO42-/CO32-). The mammalian Na+-HCO3- cotransporters can be electrogenic including a stoichiometry of 1 Na+:1 CO32-:1 HCO3- (46). In fPTCs, a CAII-SO42-/CO32- association would be stimulatory because CAII could rapidly supply the H+ necessary for the conversion of CO32- to HCO3-, thereby preventing an increase in local [CO32-] near the transporter. An association of CAII with the basolateral SO42-/OH- exchanger could also potentially stimulate transport by localized dehydroxylation of HCO3- (HCO3- -> CO2 + OH-) near the OH- transport site. The majority of CA activity (85%) and CAII protein (see Fig. 2) were found in the cytosol. CAII has been shown to accelerate the rate of CO2 diffusion (14, 48), and therefore, cytosolic CAII is likely a "facilitation factor" in substrate diffusion. Future work will be directed at identifying the renal proximal tubule SO42- transporters at the molecular level (SLC26 gene family members, e.g., Sat-1, DTDST, DRA, etc.), determining if CAII associates with these SO42- transporter(s), and determining whether this association stimulates SO42- transport and(or) CAII activity.


   DISCLOSURES
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
REFERENCES
 
This work was supported by National Science Foundation Grant IBN-0078093.


   ACKNOWLEDGMENTS
 
We thank S. Parker, E. Avery, and M. Brooks for excellent technical assistance, and the biologists of the Dominion Millstone Power Station Environmental Laboratory (National Oceanic and Atmospheric Administration/National Marine Fisheries, Milford, CT) S. Hook, NJ, and Connecticut Dept. of Environmental Protection, who provided animals. We also thank Dr. S. Gehnrich for generously providing the primers for CAII.


   FOOTNOTES
 

Address for reprint requests and other correspondence: J. L. Renfro, Physiology and Neurobiology, U-4156, Univ. of Connecticut, 3107 Horsebarn Hill Rd., Storrs, CT 06269-4156 (E-mail: larry.renfro{at}uconn.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 

  1. American Physiological Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol 283: R281-R283, 2002.[Free Full Text]
  2. Bern HA. Prolactin and osmoregulation. Am Zool 15: 937-948, 1975.
  3. Boross M, Kinsella J, Cheng L, and Sacktor B. Glucocorticoids and metabolic acidosis-induced renal transports of inorganic phosphate, calcium, and NH4. Am J Physiol Renal Fluid Electrolyte Physiol 250: F827-F833, 1986.[Abstract/Free Full Text]
  4. Breton S. The cellular physiology of carbonic anhydrases. JOP 2: 159-164, 2001.[Medline]
  5. Brion LP, Schwartz JH, Zavilowitz BJ, and Schwartz GJ. Micro-method for the measurement of carbonic anhydrase in cellular homogenates. Anal Biochem 175: 289-297, 1988.[Web of Science][Medline]
  6. Brion LP, Zavilowitz BJ, Rosen O, and Schwartz GJ. Changes in soluble carbonic anhydrase activity in response to maturation and NH4Cl loading in the rabbit. Am J Physiol Regul Integr Comp Physiol 261: R1204-R1213, 1991.[Abstract/Free Full Text]
  7. Brion LP, Zavilowitz BJ, Suarez C, and Schwartz GJ. Metabolic acidosis stimulates carbonic anhydrase activity in rabbit proximal tubule and medullary collecting duct. Am J Physiol Renal Fluid Electrolyte Physiol 266: F185-F195, 1994.[Abstract/Free Full Text]
  8. Brown D, Zhu XL, and Sly WS. Localization of membrane-associated carbonic anhydrase type IV in kidney epithelial cells. Proc Natl Acad Sci USA 87: 7457-7461, 1990.[Abstract/Free Full Text]
  9. Christianson DW and Alexander RS. Carboxylate-histidine-zinc interactions in protein structure and function. J Am Chem Soc 111: 6412-6419, 1989.
  10. Colombe L, Fostier A, Bury N, Pakdel F, and Guiguen Y. A mineralocorticoid-like receptor in the rainbow trout, Oncorhynchus mykiss: cloning and characterization of its steroid binding domain. Steroids 65: 319-328, 2000.[Web of Science][Medline]
  11. Dickman KG and Renfro JL. Primary culture of flounder renal tubule cells: transepithelial transport. Am J Physiol Renal Fluid Electrolyte Physiol 251: F424-F432, 1986.[Abstract/Free Full Text]
  12. Dudas PL and Renfro JL. Transepithelial sulfate transport by avian renal proximal tubule epithelium in primary culture. Am J Physiol Regul Integr Comp Physiol 283: R1354-R1361, 2002.[Abstract/Free Full Text]
  13. Endroczi E, Sasvary M, and Simon J. Effects of glucocorticoid treatment of the carbonic anhydrase activity of brain tissue in the early postnatal age in the rat. Acta Physiol Hung 82: 195-200, 1994.[Medline]
  14. Enns T. Facilitation by carbonic anhydrase of carbon dioxide transport. Science 155: 44-47, 1967.[Free Full Text]
  15. Freshney RI. Culture of Animal Cells. New York: Wiley-Liss, 2000, p. 577 (p. 265-266).
  16. Gehnrich SC, Lippincott LH, Swenson ER, and Maren TH. Carbonic anhydrase in the kidneys of eruryhaline fish Anguilla rostrata and Salmo salar. Bull MDIBL 33: 61-63, 1994.
  17. Gehnrich SC, Lippincott LH, Swenson ER, and Maren TH. Further attempts to separate renal from hematopoietic tissue in the euryhalne eel, Anguilla rostrata. Bull MDIBL 34: 96, 1995.
  18. Gross E, Pushkin A, Abuladze N, Fedotoff O, and Kurtz I. Regulation of the sodium bicarbonate cotransporter kNBC1 function: role of Asp986, Asp988 and kNBC1-carbonic anhydrase II binding. J Physiol 544.3: 679-685, 2002.[Abstract/Free Full Text]
  19. Gupta A and Renfro JL. Control of phosphate transport in flounder renal proximal tubule primary cultures. Am J Physiol Regul Integr Comp Physiol 256: R850-R857, 1989.[Abstract/Free Full Text]
  20. Hamilton MB, Pincus EL, Di Fiore A, and Fleischer RC. Universal linker and ligation procedures for construction of genomic DNA libraries enriched for microsatellites. Biotechniques 27: 500-507, 1999.[Web of Science][Medline]
  21. Hickman CP. Urine composition and kidney tubular function in southern flounder, Paralichthys lethostigma, in seawater. Can J Zool 46: 439-455, 1968.[Medline]
  22. Hirata T, Kaneko T, Ono T, Nakazato T, Furukawa N, Hasegawa S, Wakabayashi S, Shigekawa M, Chang MH, Romero MF, and Hirose S. Mechanism of acid adaptation of a fish living in a pH 3.5 lake. Am J Physiol Regul Integr Comp Physiol 284: R1199-R1212, 2003.[Abstract/Free Full Text]
  23. Hodler JE, Heineman HO, Fishman AP, and Smith HW. Urine pH and carbonic anhydrase activity in the marine dogfish. Am J Physiol 183: 155-162, 1955.[Free Full Text]
  24. Kaunisto K, Parkkila S, Rajaniemi H, Waheed A, Grubb J, and Sly WS. Carbonic anhydrase. XIV. Luminal expression suggests key role in renal acidification. Kidney Int 61: 2111-2118, 2002.[Web of Science][Medline]
  25. Kiefer LL and Fierke CA. Functional characterization of human carbonic anhydrase II variants with altered zinc binding sites. Biochemistry 33: 15233-15240, 1994.[Medline]
  26. Kiefer LL, Paterno SA, and Fierke CA. Hydrogen bond network in the metal binding site of carbonic anhydrase enhances zinc affinity and catalytic efficiency. J Am Chem Soc 117: 6831-6837, 1995.
  27. Li X, Alvarez B, Casey JR, Reithmeier RAF, and Fliegel L. Carbonic anhydrase II binds to and enhances activity of the Na+/H+ exchanger. J Biol Chem 277: 36085-36091, 2002.[Abstract/Free Full Text]
  28. Lucci MS, Tinker JP, Weiner IM, and DuBose TD Jr. Function of proximal tubule carbonic anhydrase defined by selective inhibition. Am J Physiol Renal Fluid Electrolyte Physiol 245: F443-F449, 1983.[Abstract/Free Full Text]
  29. Maren TH. Carbonic anhydrase: chemistry, physiology, and inhibition. Physiol Rev 47: 595-779, 1967.[Free Full Text]
  30. Maren TH, Fine A, Swenson ER, and Rothman D. Renal acid-base physiology in marine teleost, the long-horned sculpin (Myoxocephalus octodecimspinosus). Am J Physiol Renal Fluid Electrolyte Physiol 263: F49-F55, 1992.[Abstract/Free Full Text]
  31. May RC, Kelly RA, and Mitch WE. Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J Clin Invest 77: 614-621, 1986.[Web of Science][Medline]
  32. McKinley DN and Whitney PL. Particulate carbonic anhydrase in homogenates of human kidney. Biochim Biophys Acta 445: 780-790, 1976.[Medline]
  33. Parkkila S, Parkkila AK, Saarnio J, Kivela J, Karttunen TJ, Kaunisto K, Waheed A, Sly WS, Tureci O, Virtanen I, and Rajaniemi H. Expression of the membrane-associated carbonic anhydrase isozyme XII in the human kidney and renal tumors. J Histochem Cytochem 48: 1601-1608, 2000.[Abstract/Free Full Text]
  34. Quelo I, Machuca I, and Jurdic P. Identification of a vitamin D response element in the proximal promoter of the chicken carbonic anhydrase II gene. J Biol Chem 273: 10638-10646, 1998.[Abstract/Free Full Text]
  35. Renfro JL. Adaptability of marine teleost renal inorganic sulfate excretion: evidence for glucocorticoid involvement. Am J Physiol Regul Integr Comp Physiol 257: R511-R516, 1989.[Abstract/Free Full Text]
  36. Renfro JL, Maren TH, Zeien C, and Swenson ER. Renal sulfate secretion is carbonic anhydrase dependent in a marine teleost, Pleuronectes americanus. Am J Physiol Renal Physiol 276: F288-F294, 1999.[Abstract/Free Full Text]
  37. Renfro JL and Pritchard JB. H+-dependent sulfate secretion in the marine teleost renal tubule. Am J Physiol Renal Fluid Electrolyte Physiol 243: F150-F159, 1982.[Abstract/Free Full Text]
  38. Renfro JL and Pritchard JB. Sulfate transport by flounder renal tubule brush border: presence of anion exchange. Am J Physiol Renal Fluid Electrolyte Physiol 244: F488-F496, 1983.[Abstract/Free Full Text]
  39. Russell BJ, Loesebrink B, and Chernick V. Enhanced fetal erythrocyte carbonic anhydrase activity by hydrocortisone. Pediatr Res 10: 779-782, 1976.[Web of Science][Medline]
  40. Sagawa K, Darling IM, Murer H, and Morris ME. Glucocorticoid-induced alterations of renal sulfate transport. J Pharmacol Exp Ther 294: 658-663, 2000.[Abstract/Free Full Text]
  41. Sanyal G, Pessah NI, and Maren TH. Kinetics and inhibition of membrane-bound carbonic anhydrase from canine renal cortex. Biochim Biophys Acta 657: 128-137, 1981.[Medline]
  42. Schwartz GJ. Physiology and molecular biology of renal carbonic anhydrase. J Nephrol 15: S61-S74, 2002.
  43. Schwartz GJ, Winkler CA, Zavilowitz BJ, and Bargiello T. Carbonic anhydrase II mRNA is induced in rabbit kidney cortex during chronic metabolic acidosis. Am J Physiol Renal Fluid Electrolyte Physiol 265: F764-F772, 1993.[Abstract/Free Full Text]
  44. Scozzafava A and Supuran CT. Carbonic anhydrase activators: human isozyme II is strongly activated by oligopeptides incorporating the carboxyterminal sequence of the bicarbonate anion exchanger AE1. Bioorg Med Chem 12: 1177-1180, 2002.
  45. Sloman KA, Desforges PR, and Gilmour KM. Evidence for a mineralocorticoid-like receptor linked to branchial chloride cell proliferation in freshwater rainbow trout. J Exp Biol 204: 3953-3961, 2001.[Abstract/Free Full Text]
  46. Soleimani M. Na+:HCO3- cotransporters (NBC): expression and regulation in the kidney. J Nephrol 15: S32-S40, 2002.
  47. Sterling D, Reithmeier RAF, and Casey JR. A transport metabolon. J Biol Chem 276: 47886-47894, 2001.[Abstract/Free Full Text]
  48. Suchdeo SR and Schultz JS. Mass transfer of CO2 across membranes: facilitation in the presence of bicarbonate ion and the enzyme carbonic anhydrase. Biochim Biophys Acta 352: 412-440, 1974.[Medline]
  49. Suzuki M, Ren LJ, and Chen H. Further studies on the effect of aldosterone on Mg2+-HCO3--ATPase and carbonic anhydrase from rat intestinal mucosa. J Steroid Biochem 33: 89-99, 1989.[Web of Science][Medline]
  50. Suzuki S, Takamura S, Yoshida J, and Ozaki N. Effect of aldosterone antagonists on aldosterone-induced activation of Mg2+-HCO3--ATPase and carbonic anhydrase in rat intestinal mucosa. J Steroid Biochem 23: 57-66, 1985.[Web of Science][Medline]
  51. Swenson ER and Maren TH. Dissociation of CO2 hydration and renal acid secreton in the dogfish, Squalus acanthias. Am J Physiol Renal Fluid Electrolyte Physiol 250: F288-F293, 1986.[Abstract/Free Full Text]
  52. Swenson ER, Taschner BC, Miller DS, Maren TH, and Renfro JL. Presence of nonhematopoietic carbonic anhydrase in the kidneys of two saltwater teleosts, Pseudopleuronectes americanus and Fundulus heteroclitus. Bull MDIBL 35: 45-46, 1996.
  53. Tsuruoka S, Kittelberger AM, and Schwartz GJ. Carbonic anhydrase II and IV mRNA in rabbit nephron segments: stimulation during metabolic acidosis. Am J Physiol Renal Physiol 274: F259-F267, 1998.[Abstract/Free Full Text]
  54. Tsuruoka S, Swenson ER, Petrovic S, Fujimura A, and Schwartz GJ. Role of basolateral carbonic anhydrase in proximal tubular fluid and bicarbonate absorption. Am J Physiol Renal Physiol 280: F146-F154, 2001.[Abstract/Free Full Text]
  55. Vince JW, Carlsson U, and Reithmeier RAF. Localization of the Cl-/HCO3- anion exchanger binding site to the amino-terminal region of carbonic anhydrase II. Biochemistry 39: 13344-13349, 2000.[Medline]
  56. Vince JW and Reithmeier RAF. Carbonic anhydrase II binds to the carboxyl terminus of human band 3, the erythrocyte Cl-/HCO3- exchanger. J Biol Chem 273: 28430-28437, 1998.[Abstract/Free Full Text]
  57. Welbourne TC. Acidosis activation of the pituitary-adrenal-renal glutaminase I axis. Endocrinology 99: 1071-1079, 1976.[Abstract/Free Full Text]
  58. Winkler CA, Kittelberger AM, and Schwartz GJ. Expression of carbonic anhydrase IV mRNA in rabbit kidney: stimulation by metabolic acidosis. Am J Physiol Renal Physiol 272: F551-F560, 1997.[Abstract/Free Full Text]
  59. Wistrand PJ and Kinne R. Carbonic anhydrase activity of isolated brush border and basal-lateral membranes of renal tubular cells. Pflügers Arch 370: 121-126, 1977.[Web of Science][Medline]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
T. Georgalis, K. M. Gilmour, J. Yorston, and S. F. Perry
Roles of cytosolic and membrane-bound carbonic anhydrase in renal control of acid-base balance in rainbow trout, Oncorhynchus mykiss
Am J Physiol Renal Physiol, August 1, 2006; 291(2): F407 - F421.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Nakada, K. Zandi-Nejad, Y. Kurita, H. Kudo, V. Broumand, C. Y. Kwon, A. Mercado, D. B. Mount, and S. Hirose
Roles of Slc13a1 and Slc26a1 sulfate transporters of eel kidney in sulfate homeostasis and osmoregulation in freshwater
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R575 - R585.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
R. M. Pelis, S. L. Edwards, S. C. Kunigelis, J. B. Claiborne, and J. L. Renfro
Stimulation of renal sulfate secretion by metabolic acidosis requires Na+/H+ exchange induction and carbonic anhydrase
Am J Physiol Renal Physiol, July 1, 2005; 289(1): F208 - F216.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. M. Pelis and J. L. Renfro
Role of tubular secretion and carbonic anhydrase in vertebrate renal sulfate excretion
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R491 - R501.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/6/R1430    most recent
00331.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pelis, R. M.
Right arrow Articles by Renfro, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pelis, R. M.
Right arrow Articles by Renfro, J. L.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.